Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Given Imaging Guides Ingestible Microcapsule Through De Novo Process

This article was originally published in The Gray Sheet

Executive Summary

Given Imaging hopes to be the second company to have a product cleared by way of FDA's de novo program this year by proposing to include several cautionary statements in the labeling of its wireless endoscopy diagnostic imaging system.
Advertisement

Related Content

Telemetric gastrointestinal capsules
Telemetric gastrointestinal capsules
Given Imaging Goes Public, TheraSense Up Next Despite Market Uncertainties
Given Imaging Goes Public, TheraSense Up Next Despite Market Uncertainties
Given camera pill
Given camera pill
ODE Systems Approach, Revised Guidance To Enhance Premarket Programs
ODE Systems Approach, Revised Guidance To Enhance Premarket Programs
Advertisement
UsernamePublicRestriction

Register

MT015210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel